Advertisement
U.S. Markets close in 1 hr 22 mins

Imagion Biosystems Limited (IBX.AX)

ASX - ASX Delayed Price. Currency in AUD
0.0420-0.0060 (-12.50%)
At close: 03:59PM AEDT
Currency in AUD

Valuation Measures4

Market Cap (intraday) 1.81M
Enterprise Value 4.62M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.72
Price/Book (mrq)3.84
Enterprise Value/Revenue 2.46
Enterprise Value/EBITDA -1.90

Trading Information

Stock Price History

Beta (5Y Monthly) 1.98
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.4400
52 Week Low 30.0220
50-Day Moving Average 30.0403
200-Day Moving Average 30.0617

Share Statistics

Avg Vol (3 month) 3280.6k
Avg Vol (10 day) 3268.42k
Shares Outstanding 543.04M
Implied Shares Outstanding 6N/A
Float 832M
% Held by Insiders 19.10%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -106.79%
Operating Margin (ttm)-56.43%

Management Effectiveness

Return on Assets (ttm)-109.93%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)5.92M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)137.00%
Gross Profit (ttm)N/A
EBITDA -5.48M
Net Income Avi to Common (ttm)-6.32M
Diluted EPS (ttm)-0.1800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)382.45k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)3.19M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.09
Book Value Per Share (mrq)-0.16

Cash Flow Statement

Operating Cash Flow (ttm)-2.45M
Levered Free Cash Flow (ttm)-1.33M